Close
Nordic 9Nordic 9

Pioneer Group (investor - Accelerator)

United Kingdom
See something wrong or missing? Let us know
Offices:Nottingham

Pioneer Group (formerly BioCity) is the UK's largest life science incubation business,

Average round investment:3.1M USD
Average number per year:1.7
Distribution: 2025 (1)2023 (3)2021 (1)
Portfolio companies: United Kingdom ImmuONEUnited Kingdom NunaBioUnited Kingdom NuVision Biotherapies See the entire list
Mostly invests in: United Kingdom United Kingdom (5) Biotech (5)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Pioneer Group mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Pioneer Group

Name Criteria
Denmark CVX Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Michelle Kennedy
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Traditum
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Czech Republic Longevitytech.fund
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Oxford Innovation Finance
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Ben Holmes
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Germany Florian Huber
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Worth Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United Kingdom Oleg Tikhturov
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Italy Pi Campus
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top